Molecular Neurobiology, University of Bielefeld, Universitaetsstr. 25, D-33501 Bielefeld, Germany.
Eur Cell Mater. 2011 Dec 17;22:403-19. doi: 10.22203/ecm.v022a30.
Due to their broad differentiation potential and their persistence into adulthood, human neural crest-derived stem cells (NCSCs) harbour great potential for autologous cellular therapies, which include the treatment of neurodegenerative diseases and replacement of complex tissues containing various cell types, as in the case of musculoskeletal injuries. The use of serum-free approaches often results in insufficient proliferation of stem cells and foetal calf serum implicates the use of xenogenic medium components. Thus, there is much need for alternative cultivation strategies. In this study we describe for the first time a novel, human blood plasma based semi-solid medium for cultivation of human NCSCs. We cultivated human neural crest-derived inferior turbinate stem cells (ITSCs) within a blood plasma matrix, where they revealed higher proliferation rates compared to a standard serum-free approach. Three-dimensionality of the matrix was investigated using helium ion microscopy. ITSCs grew within the matrix as revealed by laser scanning microscopy. Genetic stability and maintenance of stemness characteristics were assured in 3D cultivated ITSCs, as demonstrated by unchanged expression profile and the capability for self-renewal. ITSCs pre-cultivated in the 3D matrix differentiated efficiently into ectodermal and mesodermal cell types, particularly including osteogenic cell types. Furthermore, ITSCs cultivated as described here could be easily infected with lentiviruses directly in substrate for potential tracing or gene therapeutic approaches. Taken together, the use of human blood plasma as an additive for a completely defined medium points towards a personalisable and autologous cultivation of human neural crest-derived stem cells under clinical grade conditions.
由于其广泛的分化潜力和在成年期的持久性,人类神经嵴源性干细胞(NCSC)在自体细胞治疗方面具有巨大的潜力,包括治疗神经退行性疾病和替代含有各种细胞类型的复杂组织,如在肌肉骨骼损伤的情况下。无血清方法的使用通常导致干细胞的增殖不足,而胎牛血清涉及使用异种培养基成分。因此,非常需要替代的培养策略。在本研究中,我们首次描述了一种新颖的、基于人血浆的半固体培养基,用于培养人 NCSC。我们在血浆基质中培养了人神经嵴源性下鼻甲干细胞(ITSC),与标准无血清方法相比,它们显示出更高的增殖率。使用氦离子显微镜研究了基质的三维性。激光扫描显微镜显示 ITSC 生长在基质内。通过不变的表达谱和自我更新能力,证明了 3D 培养的 ITSC 具有遗传稳定性和维持干细胞特性。预先在 3D 基质中培养的 ITSC 能够有效地分化为外胚层和中胚层细胞类型,特别是包括成骨细胞类型。此外,如这里所述培养的 ITSC 可以很容易地被慢病毒直接感染基质,用于潜在的追踪或基因治疗方法。总之,将人血浆用作完全定义培养基的添加剂,为在临床级条件下个性化和自体培养人类神经嵴源性干细胞指明了方向。